Search

Author/Creator Atkinson, J M

1. Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer. (13th November 2018)

Authors:
Sokol, E S; Feng, Y X; Jin, D X; Basudan, A; Lee, A V; Atkinson, J M; Chen, J; Stephens, P J; Frampton, G M; Gupta, P B; Ross, J S; Chung, J H; Oesterreich, S; Ali, S M; Hartmaier, R J
Journal:
Annals of oncology
Issue:
Volume 30:Number 1(2019)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer. (19th January 2018)

Authors:
Hartmaier, R J; Trabucco, S E; Priedigkeit, N; Chung, J H; Parachoniak, C A; Vanden Borre, P; Morley, S; Rosenzweig, M; Gay, L M; Goldberg, M E; Suh, J; Ali, S M; Ross, J; Leyland-Jones, B; Young, B; Williams, C; Park, B; Tsai, M; Haley, B; Peguero, J
Journal:
Annals of oncology
Issue:
Volume 29:Number 4(2018)
Page Start:
872
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗